--- title: "Pre-market hot trades in US stocks: Applied Materials pre-market down 5.01%; Marvell Tech pre-market down 4.96%" type: "News" locale: "en" url: "https://longbridge.com/en/news/291912738.md" description: "Applied Materials pre-market down 5.01%; Marvell Tech pre-market down 4.96%; Crinetics Pharmaceuticals pre-market up 99.05%; Trident Digital Tech pre-market up 71.47%; Bluejay Diagnostics pre-market up 49.14%" datetime: "2026-07-07T10:02:50.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/291912738.md) - [en](https://longbridge.com/en/news/291912738.md) - [zh-HK](https://longbridge.com/zh-HK/news/291912738.md) --- # Pre-market hot trades in US stocks: Applied Materials pre-market down 5.01%; Marvell Tech pre-market down 4.96% **Pre-market Hot Trades in US Stocks** Applied Materials is down 5.01% in pre-market trading. Based on recent key news: 1. On July 6, Citigroup analysts were optimistic about Applied Materials, as capital expenditures for wafer fabrication equipment are expected to reach $250 billion by 2028. Applied Materials has a favorable DRAM business mix and is valued lower than its industry competitors. This news pushed the stock price up nearly 6% in pre-market trading. Source: Zhitong Finance 2. On July 6, Goldman Sachs raised the target price for Applied Materials from $520 to $645, reflecting the market's optimistic expectations for its future growth. Source: Titanium Media 3. On July 4, Applied Materials had an annualized return of 24.36% over the past decade, performing well in the market, and investors remain confident in its long-term growth potential. Source: Benzinga Significant capital inflow in the semiconductor industry, risks need to be monitored. Marvell Technology is down 4.96% in pre-market trading. Based on recent key news: 1. On July 6, UBS analysts significantly raised Marvell Technology's target price from $230 to $340 while maintaining a "Buy" rating. The new target price implies nearly 39% upside from the recent closing price of about $276.70. This move reflects the market's optimistic expectations for the company's future growth, driving stock price volatility. 2. On July 6, Marvell Technology launched the industry's first 102.4 Tbps switching chip, Teralynx T100, designed for the AI era. This product is seen as one of the core drivers of the company's future growth, further enhancing market confidence in its technological innovation capabilities. 3. On July 6, analysts pointed out that although Marvell Technology's current trading price-to-earnings ratio is about 91 times, with a cumulative increase of over 200% in the past year, the high valuation has already factored in a considerable degree of optimistic expectations, and there is short-term profit-taking pressure. Significant capital inflow in the tech industry, risks need to be monitored. **Top Gainers in Pre-market US Stocks** Crinetics Pharmaceuticals is up 99.05% in pre-market trading. Based on recent key news: 1. On July 6, Fortive announced it would acquire Crinetics Pharmaceuticals for $85 per share in cash, with a total value of about $10 billion. Following this announcement, Crinetics' stock price rose over 100% in after-hours trading. 2. On July 6, Fortive stated that this acquisition would expand its business in the endocrinology field and expects the transaction to be completed in the third quarter. This news further propelled Crinetics' stock price increase. 3. On July 6, analysts changed their ratings on Crinetics, with Oppenheimer analysts downgrading their rating from Outperform to Market Perform, and Cantor Fitzgerald analysts also downgrading their rating from Overweight to Neutral. Nevertheless, analysts still believe Crinetics has a strong biotechnology pipeline The biopharmaceutical industry has shown strong performance recently, with significant capital inflows. Trident Digital Tech rose 71.47% in pre-market trading. Based on recent key news: 1. On July 6, Trident Digital Tech announced the termination of its ADS program and the transition to direct trading of common stock on NASDAQ. This move includes a 240-for-1 Cayman stock consolidation aimed at simplifying the trading structure, enhancing market liquidity, and driving a substantial increase in stock price. 2. On July 6, the company issued a statement emphasizing that it does not undertake any obligation to update any forward-looking statements unless required by law. This cautious stance may have bolstered investor confidence in the company's future stability, further supporting the rise in stock price. 3. There have been no other significant news recently. Market liquidity has increased, and risks need to be monitored. Bluejay Diagnostics rose 49.14% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows notable volatility, and specific reasons need further observation ### Related Stocks - [AMAT.US](https://longbridge.com/en/quote/AMAT.US.md) - [MRVL.US](https://longbridge.com/en/quote/MRVL.US.md) - [CRNX.US](https://longbridge.com/en/quote/CRNX.US.md) - [TDTH.US](https://longbridge.com/en/quote/TDTH.US.md) - [BJDX.US](https://longbridge.com/en/quote/BJDX.US.md) ## Related News & Research - [Jensen Huang Just Named Marvell the Next $1 Trillion Stock. Is the Stock a Buy Following a 129% Surge?](https://longbridge.com/en/news/291798501.md) - [Marvell's (MRVL) New Growth Engines Are Just Beginning to Spin](https://longbridge.com/en/news/291668978.md) - [The Unbundling of the Index: Structural Shifts in Volatility and Alternative Value Chains](https://longbridge.com/en/news/291644783.md) - [PFG Investments LLC Grows Holdings in Marvell Technology, Inc. $MRVL](https://longbridge.com/en/news/291718828.md) - [Fortitude Advisory Group L.L.C. Has $1.15 Million Stake in Marvell Technology, Inc. $MRVL](https://longbridge.com/en/news/291771288.md)